ICP4 inhibitors (Celgene)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameICP4 inhibitors (Celgene)
Drug Alias NameICP4 inhibitors (Signal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein synthesis inhibitorsVirus replication inhibitorsHSV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignal Research Division
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignal Research Division
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A